Back to REGN
Ceredex Value Advisors LLC → REGN
Ceredex Value Advisors LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
10
Latest value
$1.7M
Q3 2026
Peak value
$26.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $19.6M |
| Q4 2025 | $2.5M |
| Q1 2026 | $21.9M |
| Q1 2026 | $3.1M |
| Q2 2026 | $26.6M |
| Q2 2026 | $15.2M |
| Q2 2026 | $1.5M |
| Q3 2026 | $25.2M |
| Q3 2026 | $17.1M |
| Q3 2026 | $1.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.7M | 2.2K | — | — |
| Q3 2026 | $17.1M | 22.6K | — | — |
| Q3 2026 | $25.2M | 33.2K | — | — |
| Q2 2026 | $1.5M | 2.4K | — | — |
| Q2 2026 | $15.2M | 24.4K | — | — |
| Q2 2026 | $26.6M | 42.6K | — | — |
| Q1 2026 | $3.1M | 4.0K | — | — |
| Q1 2026 | $21.9M | 28.4K | — | — |
| Q4 2025 | $2.5M | 3.2K | — | — |
| Q4 2025 | $19.6M | 25.4K | — | — |